Retatrutide, an experimental diabetes drug, reduced A1C levels by 2 percent and body weight by 17 percent in a new late-stage ...

An informational summary of how the Akusoli Fat Burner Metabolism Bundle is described in publicly available company materials, including ingredient labeling, insole positioning, and consumer policy di ...

Accelerated approval of semaglutide 7.2 mg establishes a higher-dose, once-weekly GLP-1 RA option for long-term weight ...

The FDA has approved a higher 7.2 mg dose of Novo Nordisk’s Wegovy (Wegovy HD) for chronic weight management in adults with ...

The U.S. Food and Drug Administration expanded the use of Rhythm Pharmaceuticals’  therapy for a rare form of obesity ​caused ...

A deluge of weight-loss drugs is set to transform the global fight against obesity as India prepares to unleash low-cost ...

The Danish drugmaker said the accelerated approval was based on results from its Step Up trial, which showed 20.7% mean ...

A peer-reviewed analysis of U.S. adverse event data has found that patients taking Wegovy face nearly five times the risk of a sudden, sight-threatening eye condition compared with those on Ozempic, ...

Lean Drops, an innovative liquid dietary supplement targeting metabolic function and appetite regulation, has officially ...

Attorneys for parents and Abbott Laboratories faced off during opening arguments Monday in the first Chicago trial over ...

Used by millions of patients worldwide, the KwikPen® for single-patient use provides patients with a new option to receive Zepbound® Zepbound patients can access all doses in either multi-dose KwikPen ...

Novo's drug, CagriSema, didn't achieve its key goal of demonstrating non-inferiority on weight loss when compared to Eli Lilly's rival drug tirzepatide. The stock plummeted on Monday, hitting its ...